Ireland· IE-PA-EU/1/17/1213/001
Maviret 100 mg/40 mg film-coated tablets
A other antivirals product containing pibrentasvir + glecaprevir, registered in Ireland by AbbVie Deutschland GmbH & Co. KG. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Pibrentasvir + glecaprevir is registered in 4 of 19 countries.
Countries holding a registration under ATC J05AX (other antivirals), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Pibrentasvir + glecaprevir · ATC J05AX
4 / 19 countries
- Canada
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Pibrentasvir + Glecaprevir
- Manufacturer
- AbbVie Deutschland GmbH & Co. KG
- Country
- Ireland (IE)
- ATC code
- J05AX
- ATC class
- Other antivirals
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1213/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pibrentasvir + glecaprevir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMavyretAbbVie Inc.
- United KingdomGlecaprevir 100mg / Pibrentasvir 40mg tabletsAbbVie Ltd
- SpainMAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAbbvie Deutschland Gmbh & Co. Kg
- FinlandMaviretAbbVie Deutschland GmbH&Co.KG
- FranceMAVIRET 100 mg/40 mg, comprimé pelliculéABBVIE DEUTSCHLAND (ALLEMAGNE)
- CanadaMAVIRETABBVIE CORPORATION
- CzechiaMAVIRETAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- PolandMaviretAbbVie Deutschland GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Glecaprevir/Pibrentasvir Abbvie
- Iceland · Maviret
- Liechtenstein · Maviret
- Norway · Maviret
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd340baa-09f9-434a-9e96-80509b2177bb GET /v1/drugs/cd340baa-09f9-434a-9e96-80509b2177bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AX"
],
"strength": null,
"pa_number": "EU/1/17/1213/001",
"substances": [
"Pibrentasvir",
"Glecaprevir"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "26/07/2017",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about pibrentasvir + glecaprevir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.